Regentys, Inc.

medical devices

About

Regentys (formerly Asana Medical, Inc.) is a regenerative medicine company developing a tissue engineered therapy for the treatment of Ulcerative Colitis (UC). The Company's product ECMH, a novel application of a proven technology, will be a first-in-class therapy for patients suffering from Ulcerative Colitis. This therapy will be positioned to compete in a multi-billion-dollar market dominated by biologic and drug therapies that can have significant side effects. Additionally, 20-30% of patients do not benefit from these therapies and have no alternative except colon removal surgery. Regentys has an experienced management team, strong patent protection, world-class advisors in business and medicine, and compelling preclinical proof-of-concept data. For more information, visit www.regentys.com.

Technologies

Outlook Apache Bootstrap Framework Google Font API reCAPTCHA Django Google Tag Manager Mobile Friendly

Keywords

medical equipment manufacturing non-surgical ibd therapy regenerative medicine non-invasive therapy medical device development deep remission in ibd gi disorders regenerative scaffolds wound healing technology clinical stage biotech non-surgical treatment cell growth support extracellular matrix hydrogel tissue engineering collaborations with research institutes life sciences tissue scaffolding research and development in the physical engineering and life sciences patented medical technology healthcare technology innovative regenerative solutions ulcerative colitis b2b innovative gi treatment regenerative tissue scaffolds tissue engineering applications non-pharmacologic treatment biomaterials

Location

6135 NW 167th St, Hialeah, Florida, United States, 33015

Related Companies

Companies in the same industry